Medpace Holdings MEDP Cash Flow Statement (2015-2026)

NASDAQ MEDP
$611.39 -7.66 (-1.24%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Medpace Holdings Quarterly Cash Flow Statement

Periods 44 quarters
Latest Jun 2026

Medpace Holdings reported cash from operations of $162.01M and free cash flow of $138.10M for the quarter ended Jun 2026, up 9.1% year over year. This cash flow statement covers 44 quarters of results from Sep 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
48.57M50.03M61.31M49.36M66.03M68.67M72.89M61.07M70.55M78.30M102.59M88.35M96.43M117.02M114.59M90.26M111.14M135.13M123.87M121.36M
Share-based CompensationStock Comp.
4.05M3.98M4.37M5.65M5.79M5.59M5.44M4.91M5.01M5.17M4.31M3.59M11.73M5.89M16.89M5.95M6.32M5.62M4.92M4.35M
Deferred Taxes
0.63M-40.41M-0.71M-0.73M-0.69M-20.89M-1.06M-2.65M-7.60M-13.81M-0.86M-0.05M-1.51M-24.20M0.75M34.11M28.51M17.41M18.54M4.28M
Cash from OperationsCash from Ops.
72.35M70.89M46.26M96.62M108.49M136.68M80.08M82.52M114.39M156.40M152.68M116.40M149.07M190.67M125.84M148.53M246.21M192.65M151.79M162.01M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
5.07M5.70M5.76M5.84M5.82M6.06M5.62M5.64M5.68M5.85M6.05M
Amortization of Deferred ChargesAmort. Deferred Charges
Change in Working Capital
Change in ReceivablesChange Receivables
24.69M-0.06M38.22M0.83M23.38M4.48M4.34M17.39M17.58M8.97M-19.12M21.83M10.32M-15.27M2.07M79.91M-4.86M29.10M-7.82M47.18M
Change in Account PayablesChange Payables
2.42M-0.28M-1.04M3.59M-1.78M5.66M4.46M-2.12M-3.26M1.97M-7.35M4.90M-0.58M0.06M10.72M1.30M-10.72M1.33M0.08M-0.13M
Change in Accured ExpensesChange Accured Exp.
12.75M1.47M-3.65M19.29M32.20M4.63M-9.36M30.62M33.66M27.16M-21.13M22.05M13.02M2.95M-23.16M35.41M45.27M39.56M-1.30M45.02M
Other Working Capital ChangesOther WC Changes
21.63M40.79M22.58M34.15M16.56M44.80M-14.98M42.80M28.20M41.10M56.84M21.72M32.52M39.65M-11.59M109.78M25.55M20.06M10.17M40.16M
Investing Activities
Capital ExpendituresCapex
6.64M9.12M9.26M11.20M7.18M9.24M9.51M8.45M8.70M9.99M5.50M12.87M10.54M7.64M9.99M6.11M10.71M4.54M6.81M23.91M
Cash from Investing ActivitiesCash from Investing
-6.60M-9.12M-11.21M-11.13M-7.19M-9.22M-9.50M-8.47M-8.66M-8.00M2.53M-12.79M-10.49M-7.56M-9.99M-6.02M-10.66M-4.47M-6.75M-23.89M
Financing Activities
Other financing activitiesOther financing
1.01M2.43M13.87M1.55M0.89M5.76M2.46M1.66M5.73M1.52M7.66M0.67M6.27M1.26M25.93M0.35M7.99M22.73M12.67M6.42M
Cash from Financing ActivitiesCash from Financing
-5.21M2.43M-412.08M-123.46M-109.11M-131.12M-52.68M-82.21M-49.27M1.52M7.66M0.67M6.27M-168.61M-345.97M-540.56M3.41M22.73M12.67M-288.34M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.28M0.24M
Additional items
Exchange Rate EffectFX Effect
-1.17M-1.29M-1.43M-2.32M-3.74M0.92M0.77M0.38M-0.38M0.32M-1.31M-0.39M1.14M-1.96M2.12M2.95M0.06M0.79M-2.08M0.22M
Change in Cash
59.38M62.92M-378.46M-40.29M-11.54M-2.74M18.66M-7.78M56.07M150.24M161.56M103.88M146.01M12.54M-228.00M-395.11M239.02M211.70M155.63M-149.99M
Free Cash FlowFCF
65.71M61.78M37.00M85.42M101.31M127.44M70.56M74.07M105.68M146.41M147.18M103.53M138.54M183.02M115.84M142.41M235.50M188.12M144.97M138.10M
Net Cash FlowNCF
60.55M64.21M-377.04M-37.97M-7.80M-3.66M17.89M-8.16M56.45M149.92M162.87M104.27M144.86M14.49M-230.12M-398.06M238.96M210.91M157.71M-150.21M